Bicentric Clinical Investigation to Assess Safety and Performance of LuxBoost IOL

Recruiting N/A Interventional Study
Aphakia
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
50 and older
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
58 (estimated)
Sponsor
Cutting Edge SAS · Industry
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

The study purpose is to demonstrate safety and performance of bilateral implantation of LuxBoost intraocular lenses compared with the LuxGood Monofocal lens.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Subject aged 50 or over on the day of inclusion, presenting a * bilateral cataract for which posterior chamber IOL implantation * has been planned. * Fit within the available IOL diopter range. * Have had no previous refractive surgery. * Regular corneal astigmatism \< 1 diopt…
Contacts

Ilham XHAARD

620 050 651

ilham.xhaard@cutting-edge.fr

CONTACT

Line BETTINELLI

619 530 701

line.bettinelli@cutting-edge.fr

CONTACT